Found 60 matching trials
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE) N/A The present post-market surveillance study aims to evaluate the safety and ...
Show More Location
Hôpital Universitaire Henri Mondor
Learn More & Join Trial
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma PHASE3 Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Diet and Lifestyle Intervention Study in Postpartum Women in China PHASE2 Previous studies have shown "Doing the month", a traditional practice for p...
Show More Location
Southern Medical University
Learn More & Join Trial
Safety and Efficacy Assessments of Osalmid in Multiple Myeloma PHASE1 This study aims to evaluate the safety and efficacy of a traditional cholag...
Show More Location
Shanghai 10th People's Hospital
Learn More & Join Trial
Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation PHASE1 Primary Objectives:
* VCDI cohort:
* To determine the maximum tolerated...
Show More Location
Investigational Site Number : 250002
Learn More & Join Trial
Collection of Additional Data Followed the Study IFM 2013-04 N/A Collection of retrospective additional data (survival, biological, disease ...
Show More Location
Centre Hospitalier de la région d'Annecy
Learn More & Join Trial
Velcade (Bortezomib) Consolidation After Transplant PHASE3 The purpose of this study is to determine if bortezomib when added to conso...
Show More Location
Multiple Locations
Learn More & Join Trial
Mobilization and Outcomes After Venous Closure N/A The primary objective of this post-market registry is to collect real-world...
Show More Status
Active Not Recruiting
Location
South Denver Cardiology
Learn More & Join Trial
InSeal VCD Large Bore Vascular Closure Device Safety and Effectiveness Clinical Study NA The InSeal vascular closure device (VCD) is assessed as percutaneous closur...
Show More Location
Rabin Medical Center
Learn More & Join Trial